NCT00120510View on ClinicalTrials.gov

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

NACompletedINTERVENTIONAL
Enrollment

816

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
HIV InfectionsTuberculosis
Interventions
DRUG

Efavirenz

Non-nucleoside reverse transcriptase inhibitor dosed at 600mg taken by mouth every 24 hours at bedtime

DRUG

Lamivudine/Zidovudine

Nucleoside reverse transcriptase inhibitor dosed at 150mg/300mg fixed dose combination taken by mouth every 12 hours

Trial Locations (1)

HT-6110

Les Centres GHESKIO CIPRA CRS, Port-au-Prince

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00120510 - Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti | Biotech Hunter | Biotech Hunter